200780 — BCWorldPharm Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMicro CapNeutral

Annual income statement for BCWorldPharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	R2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS/A	ARS	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	57,030	62,079	72,703	75,111	74,814
Cost of Revenue
Gross Profit	20,496	20,098	27,403	31,963	28,045
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	59,129	63,613	70,905	68,746	73,314
Operating Profit	-2,099	-1,534	1,797	6,365	1,500
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-2,830	-2,936	-1,523	1,206	-2,766
Provision for Income Taxes
Net Income After Taxes	-2,194	-2,978	59.8	2,892	-3,316
Minority Interest
Net Income Before Extraordinary Items
Net Income	-1,580	-1,843	281	2,634	-4,433
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-1,580	-1,843	281	2,634	-4,433
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-182	-196	34.5	280	-479
Dividends per Share